Thomas Jay Lowery
Chief Tech/Sci/R&D Officer chez Satellite Biosciences, Inc.
Profil
Thomas Jay Lowery is currently the Chief Technology Officer at Satellite Biosciences, Inc. Previously, he worked as the Vice President-Diagnostics Research & Development at T2 Biosystems, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from the University of California, Berkeley.
Postes actifs de Thomas Jay Lowery
| Sociétés | Poste | Début |
|---|---|---|
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Anciens postes connus de Thomas Jay Lowery
| Sociétés | Poste | Fin |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Thomas Jay Lowery
| Brigham Young University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
